First Republic Investment Management, Inc. Xenetic Biosciences, Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$0.6 - $1.14 $12,000 - $22,799
-20,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.88 - $1.37 $8,800 - $13,700
10,000 Added 100.0%
20,000 $20,000
Q4 2021

Feb 09, 2022
BUY
$1.27 - $2.08 $12,700 - $20,800
10,000 New
10,000 $13,000
Q3 2021

Nov 12, 2021
SELL
$1.73 - $5.3 $17,300 - $53,000
-10,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.57 - $2.45 $15,700 - $24,500
10,000 New
10,000 $20,000

About Xenetic Biosciences, Inc.

XBIO Quotes by TradingView
  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $56M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email